SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-001929
Filing Date
2018-02-15
Accepted
2018-02-15 11:31:32
Documents
4
Period of Report
2018-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k012918_immudyneinc.htm 8-K 29841
2 PURCHASE AGREEMENT BY AND BETWEEN THE COMPANY AND MARK MCLAUGHLIN, DATED JANUARY f8k012918ex10-1_immudyneinc.htm EX-10.1 98351
3 FIRST AMENDMENT TO PURCHASE AGREEMENT BY AND BETWEEN THE COMPANY AND MARK MCLAUG f8k012918ex10-2_immudyneinc.htm EX-10.2 40102
4 PRESS RELEASE, DATED JANUARY 30, 2018, OF THE COMPANY f8k012918ex99-1_immudyneinc.htm EX-99.1 10685
  Complete submission text file 0001213900-18-001929.txt   180374
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18616707
SIC: 2833 Medicinal Chemicals & Botanical Products